For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Documents
Analysis of Paracetamol and Critical Impurities Under European Pharmacopoeia Conditions Utilizing a Kinetex 2.7µm C18 Core-Shell LC Column
In this technical note, utilizing a Kinetex 2.7µm C18 100 x 2.1 mm column, we were able to provide acceptable, reproducible resolution for paracetamol and the principal degradation product impurity K by using the specific HPLC parameters (particle size, column dimension, and gradient mobile phase conditions) consistent with the Ph. Eur. impurities test for paracetamol published in Supplement 9.4.2-3 The Kinetex 2.7µm C18 column we used is a direct equivalent to the specified suitable column in Pharmeuropa 28.1 revision.

Analysis of Paracetamol and Critical Impurities Under European Pharmacopoeia Conditions Utilizing a Kinetex 2.7µm C18 Core-Shell LC Column

In this technical note, utilizing a Kinetex 2.7µm C18 100 x 2.1 mm column, we were able to provide acceptable, reproducible resolution for paracetamol and the principal degradation product impurity K by using the specific HPLC parameters (particle size, column dimension, and gradient mobile phase conditions) consistent with the Ph. Eur. impurities test for paracetamol published in Supplement 9.4.2-3 The Kinetex 2.7µm C18 column we used is a direct equivalent to the specified suitable column in Pharmeuropa 28.1 revision.
Document Type:
Technical Notes
Target Industries:
Techniques:
Brands:
Separation Modes:
Reversed Phase